pharma · Molluscum Contagiosum · Common Warts (Verruca Vulgaris) · VRCA
Verrica Pharmaceuticals
Verrica Pharmaceuticals is a pharma organization headquartered in West Chester, USA. It trades on NYSE under ticker VRCA. Primary therapeutic focus areas include Molluscum Contagiosum, Common Warts (Verruca Vulgaris), Ba
West Chester, USA HQ
2013 Founded
80 Employees
Public company Type
VRCA · NYSE Ticker
Company details
- Status
- Public
- HQ
- West Chester, USA
- Founded
- 2013
- Employees
- 80
- Programs
- 7
- Drugs
- 3
- Patents
- 7
Part 1: VP-315 3 Day Dosing/Week
Phase 2 · small molecule · Basal Cell Carcinoma
Part 1: VP-315 3 Day Dosing/Week for Basal Cell Carcinoma is a Phase 2 program (small_molecule) at Verrica Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Internal code VP-315-201
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Verrica Pharmaceuticals
- Phase
- Phase 2
- Modality
- small_molecule
- Indication
- Basal Cell Carcinoma
- Status
- completed
- Trials
- 1